India is Country of Origin for Rybix, CBP Says
CBP issued a final determination of the country of origin of Rybix (tramadol hydrochloride) tablets, it said in a Federal Register notice scheduled for Jan. 11, deciding that India is the country of origin for purposes of U.S. government procurement.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
CBP concluded that tramadol hydrochloride from India, blended with excipients and packaged into dosage form in France, was not substantially transformed in France, so India is the country of origin of the finished Rybix, a pharmaceutical product used for the management of moderate to moderately severe pain in adults.
Parties have until Feb. 11 to seek judicial review of this final determination, it said. Further information: Karen Greene, 202-325-0041.